Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 206 entries
View as:

Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive

Phase: N/A Priority: Normal
NCT ID: NCT00093093 Org: User:
Start: 06/30/04 End: 05/31/06 Due: 05/31/07

A Study Comparing the Effectiveness and Safety of Extended-release Tramadol Versus Placebo in the Treatment of Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT00347724 Org: User:
Start: 11/30/00 End: 11/30/01 Due: 11/30/02

Open-Label Study to Evaluate the Effect of Rifaximin on Midazolam in Normal Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00743912 Org: User:
Start: 09/30/08 End: 11/30/08 Due: 11/30/09

Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT03664752 Org: User:
Start: 12/10/18 End: 05/07/20 Due: 05/07/21

12-Week Study of Plecanatide for CIC (The CIC3 Study)

Phase: N/A Priority: Normal
NCT ID: NCT01982240 Org: User:
Start: 11/30/13 End: 06/30/15 Due: 06/30/16

Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel

Phase: N/A Priority: Normal
NCT ID: NCT03653403 Org: User:
Start: 08/08/18 End: 06/19/19 Due: 06/19/20

Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01127503 Org: User:
Start: 06/30/10 End: 09/30/11 Due: 09/30/12

Study Evaluating the Efficacy and Safety of Subcutaneous Methylnaltrexone (MOA-728) for the Treatment of Opioid-Induced-Constipation

Phase: N/A Priority: Normal
NCT ID: NCT00936884 Org: User:
Start: 07/31/09 End: 11/30/13 Due: 11/30/14

Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03327558 Org: User:
Start: 05/15/17 End: 08/18/17 Due: 08/18/18

Pharmacokinetics and Bioavailability Comparison of Two Different Formulations of MNTX Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01366352 Org: User:
Start: 02/29/04 End: 03/31/04 Due: 03/31/05

Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI)

Phase: N/A Priority: Normal
NCT ID: NCT00401375 Org: User:
Start: 10/31/06 End: 02/29/08 Due: 02/28/09

A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products

Phase: N/A Priority: Normal
NCT ID: NCT01313728 Org: User:
Start: 12/31/10 End: 01/31/11 Due: 01/31/12

Steady-State Pharmacokinetics of Rifaximin 550 mg Tablets in Healthy and Hepatically Impaired Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03818672 Org: User:
Start: 01/29/19 End: 02/02/20 Due: 02/02/21

Study Evaluating the Safety and Tolerability of a New Intravenous Formulation of MOA-728 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00464802 Org: User:
Start: 04/30/07 End: 06/30/07 Due: 06/30/08

Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face

Phase: N/A Priority: Normal
NCT ID: NCT00952523 Org: User:
Start: 07/31/09 End: 10/31/09 Due: 10/31/10

A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of Brodalumab

Phase: N/A Priority: Normal
NCT ID: NCT02173392 Org: User:
Start: 09/30/14 End: 12/31/14 Due: 12/31/15

Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea

Phase: N/A Priority: Normal
NCT ID: NCT00547898 Org: User:
Start: 10/31/07 End: 07/11/11 Due: 07/11/12

Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone (MNTX) in Subjects With Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT01367509 Org: User:
Start: 03/31/04 End: 06/30/05 Due: 06/30/06

Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00744016 Org: User:
Start: 12/31/04 End: 10/31/07 Due: 10/31/08

Study of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02029495 Org: User:
Start: 03/31/14 End: 10/31/15 Due: 10/31/16

Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02938494 Org: User:
Start: 11/30/15 End: 09/30/16 Due: 09/30/17

(CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01100112 Org: User:
Start: 02/28/10 End: 08/31/10 Due: 08/31/11

Study of Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilitation After Orthopedic Procedures

Phase: N/A Priority: Normal
NCT ID: NCT00640146 Org: User:
Start: 10/19/07 End: 01/21/09 Due: 01/21/10

Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02785172 Org: User:
Start: 04/30/16 End: 01/31/17 Due: 01/31/18

A Study of Safety and Tolerability of Fipamezole in Adult Subjects With Parkinson's Disease Who Are Receiving Levodopa

Phase: N/A Priority: Normal
NCT ID: NCT01140841 Org: User:
Start: 06/30/10 End: 11/30/10 Due: 11/30/11